AMAG PHARMACEUTICALS (AMAG) Covered Calls

AMAG PHARMACEUTICALS covered calls A biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

You can sell covered calls on AMAG PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AMAG (prices last updated Fri 4:16 PM ET):

AMAG PHARMACEUTICALS (AMAG) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
21.85 -0.30 20.05 30.00 547K - 0.8B
Covered Calls For AMAG PHARMACEUTICALS (AMAG)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Aug 17 22 0.20 29.80 -26.2% -329.8%
Nov 16 22 1.00 29.00 -24.1% -73.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. It focuses on the development and commercialization of Feraheme injection for intravenous or IV, use to treat iron deficiency anemia or IDA. The company engages in manufacture, development and commercialization of products derived from its proprietary technology for use in treating human diseases. AMAG Pharmaceuticals was founded on 9th, November 1981 and is headquartered in Waltham, MA.